GC Cell Corp

GC Cell Corp's capital structure shows a debt-to-equity ratio of 0.43, indicating moderate leverage relative to its equity base. The company's liquidity position is concerning, with a current ratio of 0.46 and negative cash and equivalents of -43,400 KRW. Despite a price-to-book ratio of 1.88, the company's negative net income and operating income suggest a valuation not supported by current earnings. Profitability metrics are severely negative, with a return on equity of -1.46 and return on assets of -0.8985, both well below industry norms for healthcare services. The company's operating margin is -149.0%, and its net margin is -164.8%, indicating significant cost overruns or pricing pressures. These figures suggest a business model under stress, with operating and net losses far exceeding revenue. The company's geographic and segment exposure is not explicitly detailed in the input data, but its operations are centered in South Korea. Revenue concentration in a single country increases exposure to local regulatory and economic risks. No specific segment breakdown is provided, but the company's activities span testing services, cell therapy development, and bio logistics. Growth trajectory is unclear due to the absence of forward-looking guidance in the input data. Historical financials show a revenue of 165.5 billion KRW, but this is accompanied by a massive operating loss of 246.4 billion KRW and a net loss of 272.9 billion KRW. These figures suggest a company in operational distress, with no clear path to profitability in the near term. Risk factors include liquidity constraints, with negative net cash and a free cash flow of -264.5 billion KRW. The risk assessment flags dilution as low, but the company's negative cash position and high debt levels could necessitate future equity raises. No specific dilution sources are cited in the input data, but the company's financial position suggests potential for future dilution. Recent events are not detailed in the input data, but the company's financial filings indicate significant operational and financial challenges. The absence of positive cash flow from operations and the large negative free cash flow suggest a need for external financing or restructuring.